Skip to content
10-K

Annual Report

2seventy bio, Inc.

0001860782-25-000024

← back to feed
Filed
Mar 25, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 20, 2025 52.34M sh
Shares Diluted FY 2024 · Dec 31, 2024 52.22M sh
Shares Diluted FY 2024 · Dec 31, 2023 49.28M sh
Capex FY 2024 · Dec 31, 2024 $707K
Capex FY 2024 · Dec 31, 2023 $13.87M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$85M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$166.86M
Cash And Equivalents FY 2024 · Dec 31, 2024 $71.24M
Cash And Equivalents FY 2024 · Dec 31, 2023 $74.96M
Stockholders Equity FY 2024 · Dec 31, 2024 $210.81M
Stockholders Equity FY 2024 · Dec 31, 2023 $255.3M
Stockholders Equity FY 2024 · Dec 31, 2022 $310.47M
Current Liabilities FY 2024 · Dec 31, 2024 $40.09M
Current Liabilities FY 2024 · Dec 31, 2023 $59.78M
Total Liabilities FY 2024 · Dec 31, 2024 $268.7M
Total Liabilities FY 2024 · Dec 31, 2023 $310.13M
Current Assets FY 2024 · Dec 31, 2024 $187.26M
Current Assets FY 2024 · Dec 31, 2023 $237.77M
Total Assets FY 2024 · Dec 31, 2024 $479.51M
Total Assets FY 2024 · Dec 31, 2023 $565.43M
Eps Diluted FY 2024 · Dec 31, 2024 −$1.10
Eps Diluted FY 2024 · Dec 31, 2023 −$4.42
Eps Basic FY 2024 · Dec 31, 2024 −$1.10
Eps Basic FY 2024 · Dec 31, 2023 −$4.42
Sga Expense FY 2024 · Dec 31, 2024 $43.92M
Sga Expense FY 2024 · Dec 31, 2023 $69.41M
Rd Expense FY 2024 · Dec 31, 2024 $76.92M
Rd Expense FY 2024 · Dec 31, 2023 $230.76M
Net Income FY 2024 · Dec 31, 2024 −$57.25M
Net Income FY 2024 · Dec 31, 2023 −$217.57M
Operating Income FY 2024 · Dec 31, 2024 −$115.43M
Operating Income FY 2024 · Dec 31, 2023 −$237.61M
Cost Of Revenue FY 2024 · Dec 31, 2024 $0
Cost Of Revenue FY 2024 · Dec 31, 2023 $2.1M
Revenue FY 2024 · Dec 31, 2024 $37.86M
Revenue FY 2024 · Dec 31, 2023 $100.39M